| Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell … R Pati, RK Mehta, S Mohanty, A Padhi, M Sengupta, B Vaseeharan, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (6), 1195-1208, 2014 | 333 | 2014 |
| Zinc-oxide nanoparticles exhibit genotoxic, clastogenic, cytotoxic and actin depolymerization effects by inducing oxidative stress responses in macrophages and adult mice R Pati, I Das, RK Mehta, R Sahu, A Sonawane Toxicological Sciences 150 (2), 454-472, 2016 | 148 | 2016 |
| Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages S Mohanty, P Jena, R Mehta, R Pati, B Banerjee, S Patil, A Sonawane Antimicrobial agents and chemotherapy 57 (8), 3688-3698, 2013 | 112 | 2013 |
| Improvement of stability and enzymatic activity by site-directed mutagenesis of E. coli asparaginase II S Verma, RK Mehta, P Maiti, KH Röhm, A Sonawane Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1844 (7), 1219-1230, 2014 | 47 | 2014 |
| Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice RK Mehta, S Verma, R Pati, M Sengupta, B Khatua, RK Jena, S Sethy, ... Journal of Biological Chemistry 289 (6), 3555-3570, 2014 | 39 | 2014 |
| Enhancing the radiation response in KRAS mutant colorectal cancers using the c-Met inhibitor crizotinib KC Cuneo, RK Mehta, H Kurapati, DG Thomas, TS Lawrence, MK Nyati Translational Oncology 12 (2), 209-216, 2019 | 29 | 2019 |
| Transcriptomic analysis of diffuse intrinsic pontine glioma (DIPG) identifies a targetable ALDH-positive subset of highly tumorigenic cancer stem-like cells RK Surowiec, SF Ferris, A Apfelbaum, C Espinoza, RK Mehta, ... Molecular Cancer Research 19 (2), 223-239, 2021 | 25 | 2021 |
| Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors P Ray, YS Tan, V Somnay, R Mehta, M Sitto, A Ahsan, S Nyati, ... Oncotarget 7 (42), 68597, 2016 | 19 | 2016 |
| Chaperone activity and dimerization properties of Hsp90α and Hsp90β in glucocorticoid receptor activation by the multiprotein Hsp90/Hsp70-dependent chaperone machinery Y Morishima, RK Mehta, M Yoshimura, M Lau, DR Southworth, ... Molecular Pharmacology 94 (3), 984-991, 2018 | 16 | 2018 |
| Low-dose Hsp90 inhibitor selectively radiosensitizes HNSCC and pancreatic xenografts RK Mehta, S Pal, K Kondapi, M Sitto, C Dewar, T Devasia, MJ Schipper, ... Clinical Cancer Research 26 (19), 5246-5257, 2020 | 15 | 2020 |
| Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer Therapy RK Mehta, S Shukla, SG Ramanand, V Somnay, AJ Bridges, ... Translational Oncology 14 (8), 101140, 2021 | 6 | 2021 |
| Goswami C R Pati, R Mehta, S Mohanty, A Padhi, M Sengupta, V Baskarlingam Sonawane A, 1195-208, 2014 | 6 | 2014 |
| Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? AJ Bridges, RK Mehta, S Shukla, MJ Schipper, TS Lawrence, MK Nyati Oncotarget 12 (11), 1032, 2021 | 5 | 2021 |
| Combination Therapy for Cancer Treatment MK Nyati, RK Mehta US Patent App. 18/284,892, 2024 | | 2024 |
| A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancer SM Chan, Z Raglow, A Pal, SD Gitlin, M Legendre, D Thomas, RK Mehta, ... bioRxiv, 2024.03. 18.585535, 2024 | | 2024 |
| Fat Fighting Microbes RK Mehta Microbial Engineering for Therapeutics, 293-308, 2022 | | 2022 |
| Radiosensitization with the c-MET inhibitor crizotinib in KRAS mutant colorectal cancer KC Cuneo, H Kurapati, R Mehta, TS Lawrence, MK Nyati Cancer Research 77 (13_Supplement), 5840-5840, 2017 | | 2017 |
